Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.

about

Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.

P2860

Q38798449-EB605EA3-BEA5-4952-95AF-D43928376ECD

P2860

Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.

Item

http://www.wikidata.org/entity/Q41984338

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Pharmacometric Analyses to Sup ...... pinephrine Reuptake Inhibitor.

@en

type

Item

label

Pharmacometric Analyses to Sup ...... pinephrine Reuptake Inhibitor.

@en

prefLabel

Pharmacometric Analyses to Sup ...... pinephrine Reuptake Inhibitor.

@en

P1476

Pharmacometric Analyses to Sup ...... pinephrine Reuptake Inhibitor.

@en

P2093

C M Rubino

http://www.w3.org/2001/XMLSchema#string

E Raddad

http://www.w3.org/2001/XMLSchema#string

J S Sloan-Lancaster

http://www.w3.org/2001/XMLSchema#string

J W Miller

http://www.w3.org/2001/XMLSchema#string

M R Melhem

http://www.w3.org/2001/XMLSchema#string

S A Van Wart

http://www.w3.org/2001/XMLSchema#string

P2860

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression.

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

Role of modelling and simulation in Phase I drug development.

Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making.

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications.

Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

P304

e66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PSP.2013.43

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256075963

http://www.w3.org/2001/XMLSchema#string

P698

23965782

http://www.w3.org/2001/XMLSchema#string

P921

norepinephrine

P932

3828007

http://www.w3.org/2001/XMLSchema#string

Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.

about

P2860

P2860

Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932